Search Videos and More

Showing 1 - 12 of 18 results

Previous| 1 | 2 |Next


Temple University Hospital and Fox Chase Cancer Center Researchers Characterize HER2 Mutations in Patients With Lung Adenocarcinoma News

Temple University Hospital and Fox Chase Cancer Center Researchers Characterize HER2 Mutations in Patients With Lung Adenocarcinoma

Human epidermal growth factor 2 (HER2) mutations can be identified in up to 6% of non-small cell lung cancer cases where KRAS, EGFR, or ALK gene mutations are also found, according to the results of research from Temple University Hospital and Fox Chase Cancer Center presented today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
Fox Chase Researchers Present Data on Integrating Palliative Care Education Into Hematology-Oncology Fellowships News

Fox Chase Researchers Present Data on Integrating Palliative Care Education Into Hematology-Oncology Fellowships

A new integrated palliative care rotation for hematology/oncology fellows improved their palliative care knowledge and skill confidence, according to results of a pilot study presented today by Fox Chase Cancer Center researchers at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community News

Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community

Clinical trials are among the most important resources when it comes to effectively treating challenging cases of cancer, but at Fox Chase Cancer Center, these trials encompass much more than just testing new drug candidates that may be more effective alternative treatments.
A One-Stop Shop for Liver Cancer News

A One-Stop Shop for Liver Cancer

Fox Chase Improves Treatment and Access to It
Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life. News

Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.

Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment News

New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment

Could NanoKnife be the future of prostate cancer care?
A Salvage Treatment Jennifer Was Inspired to Salvage. News

A Salvage Treatment Jennifer Was Inspired to Salvage.

A Life-Saving Idea for Bladder Cancer Patients.
Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment News

Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment

Bladder removal is life-altering. This study examines when and why some patients may not need it.
The New Department of Urology at Fox Chase Cancer Center News

The New Department of Urology at Fox Chase Cancer Center

Built on strength: world-class specialists, innovative researchers, and clinical leaders.
Transforming Cancer Care and Delivery News

Transforming Cancer Care and Delivery

The new President and CEO of Fox Chase Cancer Center
A $1.4 Million Grant Looks at Prostate Cancer Through a ‘Neighborhood Lens.’ News

A $1.4 Million Grant Looks at Prostate Cancer Through a ‘Neighborhood Lens.’

Where a man is born, lives and works can influence his prostate cancer diagnosis, treatment, and survival. But which factors matter most? And what role do they all play together in how he responds to cancer treatment?
Research on Making Cancer “Catch” the Flu Wins International Acclaim in Nature News

Research on Making Cancer “Catch” the Flu Wins International Acclaim in Nature

Turning a "cold" tumor "hot" to fight advanced melanoma.

Showing 1 - 12 of 18 results

Previous| 1 | 2 |Next